Library

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    Electronic Resource
    Electronic Resource
    Springer
    Journal of molecular medicine 60 (1982), S. 1060-1062 
    ISSN: 1432-1440
    Keywords: Histamine H2 antagonist ; Acid aspiration ; Pneumonitis ; Gastric pH ; Gastric volume ; Histamin H2-Antagonisten ; Aspirationspneumonie ; Magensaft pH ; Magensaftvolumen
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Description / Table of Contents: Zusammenfassung Der Histamin H2-Antagonist Cimetidin wurde 63 Patienten vor elektiven allgemeinchirurgischen Eingriffen in 2 verschiedenen Regimes verabreicht: Eine Gruppe erhielt 400 mg per os 10–12 h vor der Operation, eine zweite 400 mg per os 10–12 h plus 200 mg intravenös 1–2 h vor Operationsbeginn. Es wurde eine signifikant größere Anzahl von Patienten mit einem pH 〉2,5 in den Cimetidin-behandelten Gruppen nur gefunden, wenn man den ganzen Zeitraum der Narkose mit berücksichtigte. Nach diesen Ergebnissen wird Cimetidin bei elektiven Eingriffen als nicht notwendige Routineprämedikation erachtet.
    Notes: Summary Cimetidine, a histamine H2-receptor-antagonist, was administered either as a single 400 mg dose perorally 10–12 h before operation, or in a 400 mg dose perorally 10–12 h before operation plus 200 mg intravenously 1–2 h before operation, in 63 patients awaiting general elective surgery. Distribution of patients showed a significantly greater number of patients with a pH 〉2.5 in cimetidine groups, as compared to controls only, if the whole time of anaesthesia is taken into consideration. Between the two cimetidine regimens there was no statistically significant difference. These findings suggest that cimetidine is not necessary as a routine pre-operative medication in general elective surgery.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...